Crigler-Najjar syndrome type 2 complicating cholecystitis in a patient with UGT1A1 gene double homozygous mutations

Jianhui Zhang; Rongrong Chen; Xiang Chen; Ying Chen; Qilin Chen; Shiyun Lu; Jiewei Luo; Xiaoling Zheng; Mengshi Chen

doi:10.1007/s11684-025-1142-6

Front. Med. ›› 2025, Vol. 19 ›› Issue (4) : 675 -680. DOI: 10.1007/s11684-025-1142-6

CASE REPORT

Crigler-Najjar syndrome type 2 complicating cholecystitis in a patient with UGT1A1 gene double homozygous mutations

Jianhui Zhang ¹^,²^,^‡
, Rongrong Chen ¹^,³^,^‡
, Xiang Chen ⁴^,^‡
, Ying Chen ¹^,^‡
, Qilin Chen ¹^,²^,^‡
, Shiyun Lu ¹^,³^,^†^,^‡
, Jiewei Luo ¹^,^†^,^‡
, Xiaoling Zheng ¹^,²^,^†^,^‡
, Mengshi Chen ¹^,³^,^†^,^‡

Author information +

History +

PDF (2603KB)

Abstract

Crigler-Najjar syndrome (CNS) and Gilbert syndrome (GS; OMIM: 143500) are rare autosomal recessive diseases that cause unconjugated hyperbilirubinemia due to decreased UGT1A1 enzyme activity. Crigler-Najjar syndrome type 2 (CNS2; OMIM: 606785) increases the risk of gallbladder stone formation and cholecystitis, while GS seldom causes health issues. We found a 28-year-old male patient with recurring right upper abdomen pain who experienced persistent jaundice from birth. CNS2 with gallbladder stones and cholecystitis was diagnosed after genetic testing revealed rare double homozygous mutations A(TA)₇TAA (rs3064744) and P229Q (rs35350960) in the UGT1A1 gene. After pedigree investigation, we found that the patient’s parents with modestly increased bilirubin had compound heterozygous mutations A(TA)₇TAA and P229Q, which were GS. Bioinformatics analysis showed that A(TA)₇TAA is in the TATA-box region of the gene UGT1A1 promoter, affecting gene transcriptional initiation, whereas P229Q modifies protein three-dimensional structure and may be harmful. In this pedigree, double homozygous mutations have a more severe phenotype than compound heterozygous mutations. Inherited causes of hyperbilirubinemia should be suspected after ruling out biliary obstruction, and early bilirubin reduction (< 103 μmol/L (6 mg/dL)) may reduce the risk of complications like cholecystitis in CNS2 patients, though further studies with longer follow-up are needed to confirm this observation.

Keywords

Crigler-Najjar syndrome / Gilbert syndrome / UGT1A1 gene / double homozygous mutations

Cite this article

Download citation ▾

Jianhui Zhang, Rongrong Chen, Xiang Chen, Ying Chen, Qilin Chen, Shiyun Lu, Jiewei Luo, Xiaoling Zheng, Mengshi Chen. Crigler-Najjar syndrome type 2 complicating cholecystitis in a patient with UGT1A1 gene double homozygous mutations. Front. Med., 2025, 19(4): 675-680 DOI:10.1007/s11684-025-1142-6

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Abuduxikuer K, Fang LJ, Li LT, Gong JY, Wang JS. UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: a retrospective analysis and quantitative correlation. Medicine (Baltimore) 2018; 97(49): e13576

[2]	Ebrahimi A, Rahim F. Crigler-Najjar syndrome: current perspectives and the application of clinical genetics. Endocr Metab Immune Disord Drug Targets 2018; 18(3): 201–211

[3]	BhandariJThada PKShahMYadavD. Crigler-Najjar Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2025

[4]	Sambati V, Laudisio S, Motta M, Esposito S. Therapeutic options for Crigler-Najjar syndrome: a scoping review. Int J Mol Sci 2024; 25(20): 11006

[5]

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–424

[6]	Bai J, Li L, Liu H, Liu S, Bai L, Song W, Chen Y, Zheng S, Duan Z. UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults. J Clin Transl Hepatol 2021; 9(2): 180–186

[7]	Li L, Deng G, Tang Y, Mao Q. Spectrum of UGT1A1 variations in Chinese patients with Crigler-Najjar syndrome type II. PLoS One 2015; 10(5): e0126263

[8]	Vítek L, Tiribelli C. Gilbert’s syndrome revisited. J Hepatol 2023; 79(4): 1049–1055

[9]	Maruo Y, Nakahara S, Yanagi T, Nomura A, Mimura Y, Matsui K, Sato H, Takeuchi Y. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome. J Gastroenterol Hepatol 2016; 31(2): 403–408

[10]	Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert’s syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta Mol Basis Dis 1998; 1406(3): 267–273

[11]	Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology 2014; 146(7): 1625–1638

[12]	Wu L, Li Z, Song Y, Li Y, Zhang W, Zhong X, Wang X, Huang J, Ou X. Analysis of UGT1A1 genotype-phenotype correlation in Chinese patients with Gilbert and Crigler-Najjar II syndrome. Eur J Med Genet 2024; 71: 104962

[13]	Sun L, Li M, Zhang L, Teng X, Chen X, Zhou X, Ma Z, Qi L, Wang P. Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II. Medicine (Baltimore) 2017; 96(45): e8620

[14]

Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, Uemura K, Umezawa A, Katanuma A, Katayose Y, Suzuki Y, Shoda J, Tsuyuguchi T, Wakai T, Inui K, Unno M, Takeyama Y, Itoi T, Koike K, Mochida S. Evidence-based clinical practice guidelines for cholelithiasis 2021. J Gastroenterol 2023; 58(9): 801–833

[15]	Han H, Zheng K. Effect of preoperative jaundice on complications of laparoscopic cholecystectomy combined with intraoperative biliary stone removal in patients with common bile duct stones. Chin J Bases Clin Gen Surg (Zhongguo Pu Wai Ji Chu Yu Lin Chuang Za Zhi) 2019; 26(7): 828–833